Importantly, pharmacological inhibition of GART using LMX not only induces NB differentiation but also significantly attenuates tumor cell proliferation, offering a compelling dual‐targeting approach for high‐risk NB treatment. The gene discussed is GART; the disease is neuroblastoma.